Virtual reality is providing new experiences to both HCPs and patients; deepening learning and high quality trainings for HCPs, and, on the other hand, an empathy treatment for patients. Virtual reality or 360-degree video can help address medicine adherence by telling the story of patient journeys through deep visualizations of their conditions, disease states or therapies.
Using virtual reality not only increases the efficiency of the pre development phases, it also enables the scientists to better visualize the interactions and thus redesign and re engineer molecules according to site specifications.
A virtual tech is a powerful tool for representing information, especially the more complex concepts, and ideas – the likes you’d encounter in medical science. We have already mentioned before how VR is used for visualizing physiological processes, “handling” models of chemical compounds and molecules, etc.
It has always been better to see such things once for yourself than trying to figure it all out by contemplating dozens of pages of written descriptions. It’s no wonder, then, that medical specialists are highly interested.
Modern VR also builds upon mechanism of action (MOA) animations, which are a mainstay in pharmaceutical marketing. While MOAs provide clear and concise information about drugs, most animations offer the patients or hcp´s the experience of “being” in the bloodstream or penetrating a cell wall to deliver healing medicine.
Pharmaceutical companies can also use VR technology to promote brand awareness. Consumers are far more likely to remember the extraordinary experience of virtual reality than a PowerPoint presentation, that´s a fact.
Pharma companies can use VR in medical conventions rather than hauling around heavy, expensive equipment. Virtual reality also helps convention attendees explore mechanism of action in a completely new and engaging way.
VR and AR could help improve care and outcomes for patients and allow healthcare providers to better communicate therapy options. Complex medical information can be broken down into simple, visual concepts that can be downloaded through an app and viewed on a smartphone.
AR/VR and the combination of Artificial Intelligence can be a path breaking frontier for pharma research. An intelligently adapting AR/VR enabled research platform can have the ability to create huge bodies of knowledge that can used for tackling major health concerns.
While big pharmaceutical companies have started adopting AR/VR and there have been many successful use cases, the easy availability of these technologies, smaller pharmaceutical companies can also start using them. Not only do these technologies have the ability to cut costs for various processes and improve outcomes, they can also give adopters a significant advantage in this increasingly competitive pharmaceutical landscape.
Some attendees at 3DforScience´s booth in the last BIO Convention in Philadelphia 2019 trying virtual reality immersive experiences with our VR googles.